TrialCancer chemotherapy and pharmacology2018

Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC).

Takahiro Nakayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.